Flow Pharma FlowVax™ Adjuvanted Microsphere Peptide Vaccine for COVID-19
Flow Pharma is developing FlowVax COVID-19, which is being designed to generate a robust immune response to protect individuals against infection with SARS-CoV-2, by targeting parts of the virus least likely to mutate. FlowVax COVID-19 is a room temperature stable dry powder not requiring refrigeration, and is being developed for delivery by injection or inhalation.
3451 Vincent Road
Pleasant Hill CA, 94523